Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Cullis

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|October 1, 1991
Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cellsY Z Jiang, E J Kanfer, D Macdonald, et al.
British Journal of Haematology|April 8, 1998
Acute leukaemia in Jehovah's WitnessesJ O Cullis, A S Duncombe, J M Dudley, et al.
Blood|March 1, 1992
Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantationJ O Cullis, Y Z Jiang, A P Schwarer, et al.
British Journal of Haematology|January 1, 1992
Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioningJ O Cullis, A P Schwarer, T P Hughes, et al.
British Journal of Haematology|February 1, 2006
Obtaining consent for chemotherapyJ Treleaven, J O Cullis, R Maynard, et al.
British Journal of Haematology|July 1, 1992
Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five casesJ O Cullis, D I Marks, A P Schwarer, et al.
Blood|June 1, 1994
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapseF van Rhee, F Lin, J O Cullis, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
British Journal of Haematology|July 1, 1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeD I Marks, T P Hughes, R Szydlo, et al.
British Journal of Haematology|October 24, 2006
Guidelines on the management of acute myeloid leukaemia in adults, D W Milligan, D Grimwade, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|October 1, 1991
Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cellsY Z Jiang, E J Kanfer, D Macdonald, et al.
British Journal of Haematology|April 8, 1998
Acute leukaemia in Jehovah's WitnessesJ O Cullis, A S Duncombe, J M Dudley, et al.
Blood|March 1, 1992
Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantationJ O Cullis, Y Z Jiang, A P Schwarer, et al.
British Journal of Haematology|January 1, 1992
Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioningJ O Cullis, A P Schwarer, T P Hughes, et al.
British Journal of Haematology|February 1, 2006
Obtaining consent for chemotherapyJ Treleaven, J O Cullis, R Maynard, et al.
British Journal of Haematology|July 1, 1992
Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five casesJ O Cullis, D I Marks, A P Schwarer, et al.
Blood|June 1, 1994
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapseF van Rhee, F Lin, J O Cullis, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
British Journal of Haematology|July 1, 1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeD I Marks, T P Hughes, R Szydlo, et al.
British Journal of Haematology|October 24, 2006
Guidelines on the management of acute myeloid leukaemia in adults, D W Milligan, D Grimwade, et al.
Pageof 3